Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 250 Leukemia 186 Lymphoma 137 Leukemia, Myeloid, Acute 103 Burkitt Lymphoma 90 Myelodysplastic Syndromes 79 Lymphoma, Non-Hodgkin 65 Breast Neoplasms 60 Lymphoma, Large B-Cell, Diffuse 59 Leukemia, Lymphocytic, Chronic, B-Cell 49 Lymphoma, Mantle-Cell 47 Hodgkin Disease 47 Graft vs Host Disease 46 Lymphoma, Follicular 45 Leukemia, Myeloid, Accelerated Phase 45 Multiple Myeloma 39 Leukemia, Myeloid, Chronic-Phase 39 Congenital Abnormalities 39 Myeloproliferative Disorders 38 Blast Crisis 38 Leukemia, Myelomonocytic, Chronic 37 Leukemia, Biphenotypic, Acute 35 Recurrence 34 Lymphoma, Large-Cell, Immunoblastic 33 Lymphoma, B-Cell, Marginal Zone 31 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 30 Osteosarcoma 29 Primary Myelofibrosis 27 Neoplasms, Plasma Cell 25 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 25

Interventions

pyrrolidine 1 pirarubicin 1 olaparib 1 ixabepilone 1 exemestane 1 eribulin 1 apatinib 1 Vinorelbine 1 Trastuzumab 1 Toremifene 1 Tamoxifen 1 Paclitaxel 1 Methotrexate 1 Letrozole 1 Gemcitabine 1 Fulvestrant 1 Fluorouracil 1 Epirubicin 1 Endostatins 1 Doxorubicin 1 Cyclophosphamide 1 Cisplatin 1 Carboplatin 1 Capecitabine 1 Bevacizumab 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Cancer Organoids × Methotrexate × Clear all

NCT03925233 2019-04-24

Breast Cancer Treatment Based on Organ-like Culture

Xijing Hospital

Breast Cancer Organoids

Data powered by HemOnc (CC BY 4.0) Colophon ⚡